September 9, 2010
|
Contact MDS
Our Company
Our Markets
Our Businesses
For Investors
For Media
For Potential
Employees
Strategic
Repositioning of MDS
For Investors
Investor Overview
Stock Info
Stock Quote
Historical Price Lookup
Investment Calculator
Dividend Information
News & Events
News Releases
2010
2009
2008
2007
2006
2005
In the News
2010
2009
2008
2007
Calendar of Events
Webcasts & Presentations
Financial Information
Annual Reports
Archived Reports
Financial Results
Supplemental Information
SEDAR
EDGAR
Investor Resources
Risk Factors
Financial Summary
Investor Kit
Report Request Form
Analyst Coverage
General FAQs
Dividend Info
Corporate Governance
Corporate Governance
Annual Report
Proxy Circular
Directors and Management
Board of Directors
Executive Management Team
Compensation of Directors
Board and Committee Charters
Guidelines & Practices
Disclosure Required by Section 303A.11 of NYSE
Global Business Practice Standards
Subscribe
E-mail Alerts
RSS
Contacts
Strategic Repositioning
Substantial Issuer Bid
General FAQs
Contact MDS Nordion
Home
>
News Releases 2004
12-24-2004
MDS Pharma Services Responds to FDA Correspondence
12-15-2004
MDS Reports Fiscal 2004 Financial Results
12-09-2004
MDS Announces Quarterly Dividend
10-28-2004
MDS Inc. Announces Retirement of Wilfred G. Lewitt As Chairman of the Board
10-28-2004
MDS Pharma Services Announces New Senior Management Team and Structure
10-25-2004
Applied Biosystems and MDS Inc. Complete Transaction
10-07-2004
MDS Pharma Services Appoints New President
10-01-2004
MDS Inc. Holdings in Evolved Digital Systems Inc.
09-27-2004
MDS Sciex Announces Plan for Manufacturing Facility in Singapore
09-24-2004
MDS Announces Sale of Memphis Pathology Laboratory
09-09-2004
MDS Reports Third Quarter Fiscal 2004 Financial Results
09-01-2004
Applied Biosystems and MDS Expand Joint Venture in Mass Spectrometry
07-29-2004
MDS Inc. Announces Completion of Proteomics Reorganization
06-17-2004
MDS Inc. normal course issuer bid
06-02-2004
MDS Reports Second Quarter Fiscal 2004 Financial Results
06-01-2004
MDS Inc. Supports Proteomics New Business Plan and Financial Reorganization
05-06-2004
MDS Inc. Repositions Executive Management Team - Creates Chief Operating Officer Position
05-03-2004
MDS Inc. Announces Completion of Hemosol Transaction
03-16-2004
MDS Announces Sale of Laboratory Operations in New York and Georgia to LabCorp(R)
03-04-2004
MDS Reports First Quarter Fiscal 2004 Financial Results
02-12-2004
MDS Inc. to Benefit From Hemosol Tax Losses
01-07-2004
MDS Inc. Appoints David Poirier as President, Enterprise Services
01-06-2004
John T. Mayberry Joins MDS Inc. Board